• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Catalog Number 210101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 10/31/2019
Event Type  Injury  
Event Description
Male underwent aquablation procedure.It was reported that prior to the aquablation procedure, the patient had undergone a laser bladder stone procedure and had been bleeding for a week post-procedurally.Prior to the aquablation procedure, a cystoscopy was performed to assess the patient and several clots were removed.The physician noted that the patient began to bleed during the cystoscopy assessment.There was bleeding observed during the aquabeam handpiece insertion as well.Post-aquablation procedure, clot evacuation was performed along with light unipolar cauterization (with loop) at the bladder neck.Per standard post-operative procedure, the patient was catheterized with a foley balloon catheter inflated at 60 cc with light bladder neck traction, which achieved good color in catheter.The catheter was then flushed without continuous bladder irrigation (cbi) and patient was taken into the post-anesthesia care unit (pacu).Approximately an hour later, the pacu staff attempted to flush the catheter and start cbi, but the catheter was blocked due to clots and had to be replaced.A new catheter was inserted, inflated to 60 cc, and cbi was started about 105 minutes post-aquablation procedure.The patient became hypotensive and was administered medication.The physician reported that the patient's hemoglobin (hgb) level dropped from 12.1 g/dl pre-procedure to 8.1 g/dl in the pacu, therefore the patient received two (2) units of blood transfusion.Per manufacturer's instructions for use, bleeding is a potential risk after aquablation procedure.No other clinical sequela was reported with the patient.No malfunction of the aquabeam robotic system was reported.
 
Manufacturer Narrative
The aquabeam system's log file was reviewed, which confirmed no malfunctions related to the reported event.The review of the log file indicated that the system functioned as designed.A review of the device history record (dhr) for lot number 18c00487 was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system.The review indicated that the system met all required specifications when released for distribution.A review for similar complaints was performed on the aquabeam system's, lot number 18c00487, which confirmed that there was one (1) other similar event reported on this lot.The aquabeam robotic system's instructions for use (ifu), ifu310301, rev.F, was reviewed and bleeding is listed as a potential perioperative risk of the aquablation procedure.The system was not returned for investigation of this complaint.Bleeding is a potential risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.Corrected data: for corrected data, please refer to the following: suspect medical devce, catalog #, lot #, udi #.Initial reporter, name and address, device manufacturer date.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM ROBOTIC SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
MDR Report Key9378292
MDR Text Key168443389
Report Number3012977056-2019-00061
Device Sequence Number1
Product Code PZP
UDI-Device IdentifierB614AB20001
UDI-PublicB614AB20001
Combination Product (y/n)N
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number210101
Device Lot Number18C00487
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/28/2019
Initial Date FDA Received11/26/2019
Supplement Dates Manufacturer Received12/12/2019
Supplement Dates FDA Received12/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-